Effect of levodopa on the interpretation of social interactions in people living with Parkinson’s disease
Objective: Better understand the social interactions by assessing the effect of oral levodopa on the social cognition abilities in fluctuating PD patients without significant cognitive disorder.…Prediction of postoperative delirium after deep brain stimulation surgery in Parkinson`s disease
Objective: - To identify risk factors for postoperative delirium (POD) after deep brain stimulation (DBS) surgery- To personalize and optimize perioperative management Background: The main…Prevalence of depression and cognitive impairment in a Hungarian Parkinson’s disease Center
Objective: Our aim is to determine the prevalence of depression and cognitive impairment (CI) among our PD patients. Background: Depression and CI are the most…Adult hippocampal neurogenesis-associated memory performance in people with Parkinson’s disease with and without cognitive impairment
Objective: To evaluate the role of adult hippocampal neurogenesis (AHN)-associated memory measures to the cognitive performance of people with Parkinson’s disease (PwP) with or without…The effects of mental imagery on balance, anxiety and quality of life of older people with early stage of dementia: Preliminary data
Objective: To examine the effectiveness of MI on balance; anxiety and quality of life of older adults with early stage of dementia. Background: Dementia is…Verbal Fluency Changes After Unilateral STN Deep Brain Stimulation in Parkinson’s Disease: A Connectomics-Based Approach
Objective: To investigate neural circuitry associated with verbal fluency changes after STN-DBS in Parkinson’s disease. Background: Despite its substantial motor benefits, subtle cognitive changes can…24(S)-Hydroxycholesterol and cognition in Huntington’s disease: results from two large patient cohorts (TRACK-HD and ENROLL-HD)
Objective: To investigate correlations between plasma levels of 24(S)-Hydroxycholesterol (24[S]-HC) and cognitive performance in participants with Huntington’s disease (HD) using data from ENROLL-HD. Background: HD…Evaluation of Cognitive Assessment Tools in Parkinson’s Disease
Objective: To evaluate a variety of cognitive assessment scales in a longitudinal Parkinson’s disease (PD) cohort. Background: Cognitive impairment is one of the most common and…Extent of cognitive impairment in Parkinson`s disease with Covid-19
Objective: To study of the extent of cognitive impairment in PD patients with Covid-19. Background: Covid-19 may aggravate the clinical course of Parkinson's disease (PD)…Gut microbiota dysbiosis in Parkinson’s disease patients: a potential biomarker of disease severity and progression?
Objective: To investigate gut microbiota alterations in Parkinson's disease (PD) along disease progression. Background: Gut microbiota dysbiosis is considered a hallmark in PD1. However, it is…
- « Previous Page
- 1
- …
- 14
- 15
- 16
- 17
- 18
- …
- 117
- Next Page »